Results 61 to 70 of about 257,444 (202)

Applications of Yeast Surface Display for Protein Engineering [PDF]

open access: yes, 2015
The method of displaying recombinant proteins on the surface of Saccharomyces cerevisiae via genetic fusion to an abundant cell wall protein, a technology known as yeast surface display, or simply, yeast display, has become a valuable protein engineering tool for a broad spectrum of biotechnology and biomedical applications.
Gerald M, Cherf, Jennifer R, Cochran
openaire   +2 more sources

WormBase 2007 [PDF]

open access: yes, 2008
WormBase (www.wormbase.org) is the major publicly available database of information about Caenorhabditis elegans, an important system for basic biological and biomedical research. Derived from the initial ACeDB database of C. elegans genetic and sequence
A. Petcherski   +51 more
core   +3 more sources

Cell surface display of functional human MHC class II proteins: yeast display versus insect cell display [PDF]

open access: yesProtein Engineering, Design and Selection, 2011
Reliable and robust systems for engineering functional major histocompatibility complex class II (MHCII) proteins have proved elusive. Availability of such systems would enable the engineering of peptide-MHCII (pMHCII) complexes for therapeutic and diagnostic applications.
Fei, Wen   +3 more
openaire   +2 more sources

Dual Function pH Responsive Bispecific Antibodies for Tumor Targeting and Antigen Depletion in Plasma

open access: yesFrontiers in Immunology, 2019
Shedding of membrane-bound cell surface proteins, where the extracellular domain is released and found in the circulation is a common phenomenon. A prominent example is CEACAM5 (CEA, CD66e), where the shed domain plays a pivotal role in tumor progression
Jan P. Bogen   +6 more
doaj   +1 more source

Preferential Identification of Agonistic OX40 Antibodies by Using Cell Lysate to Pan Natively Paired, Humanized Mouse-Derived Yeast Surface Display Libraries

open access: yesAntibodies, 2019
To discover therapeutically relevant antibody candidates, many groups use mouse immunization followed by hybridoma generation or B cell screening. One modern approach is to screen B cells by generating natively paired single chain variable fragment (scFv)
Angélica V. Medina-Cucurella   +14 more
doaj   +1 more source

Accounting for the Role of Long Walks on Networks via a New Matrix Function [PDF]

open access: yes, 2016
We introduce a new matrix function for studying graphs and real-world networks based on a double-factorial penalization of walks between nodes in a graph. This new matrix function is based on the matrix error function.
Estrada, Ernesto, Silver, Grant
core   +2 more sources

Empirical study on clique-degree distribution of networks [PDF]

open access: yes, 2007
The community structure and motif-modular-network hierarchy are of great importance for understanding the relationship between structures and functions. In this paper, we investigate the distribution of clique-degree, which is an extension of degree and ...
Bing-Hong Wang   +9 more
core   +1 more source

Yeast surface display for protein engineering and characterization

open access: yesCurrent Opinion in Structural Biology, 2007
Yeast surface display is being employed to engineer desirable properties into proteins for a broad variety of applications. Labeling with soluble ligands enables rapid and quantitative analysis of yeast-displayed libraries by flow cytometry, while cell-surface selections allow screening of libraries with insoluble or even as-yet-uncharacterized binding
Gai, S Annie, Wittrup, K Dane
openaire   +2 more sources

Validation of glypican-3-specific scFv isolated from paired display/secretory yeast display library

open access: yesBMC Biotechnology, 2012
Background Glypican-3 (GPC3) is a heparan-sulfate proteoglycan frequently expressed on the cell membrane of malignant hepatocytes in hepatocellular carcinoma.
Li Yonghai   +3 more
doaj   +1 more source

Visualizing mitochondrial FoF1-ATP synthase as the target of the immunomodulatory drug Bz-423

open access: yes, 2018
Targeting the mitochondrial enzyme FoF1-ATP synthase and modulating its catalytic activities with small molecules is a promising new approach for treatment of autoimmune diseases. The immuno-modulatory compound Bz-423 is such a drug that binds to subunit
Börsch, Michael   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy